Default Category
-
Valeant Pharmaceuticals: Eroded Reputation and Stock Price
Mary Gillett; Amy HorrocksCase IVEY-9B20B014-EAccounting and ControlIn early January 2019, a recent Ivey Business School graduate logged into her online trading account to review her portfolio’s performance. As she scanned her investments, she paused at one stock in particular. It was time to make a decision regarding one of her most volatile stocks—Valeant Pharmaceuticals International Inc., recently renamed Bausch Health Companies Inc. The pharmaceutical company was once celebrated for its innovative business a...Starting at €8.20
-
Diamond Estate Wines & Spirits Inc.: Growth Challenges in a Fragmented Industry
Ann Dulhanty; John LoveCase IVEY-9B19M139-EStrategyIn 2019, 15 years after entering the Canadian wine industry, Diamond Estate Wines & Spirits Inc. (Diamond), located in the Niagara Peninsula of Ontario, was poised for growth. In a fragmented industry with local, national, and international competition frStarting at €8.20